- Home
- ORIC vs HPP Comparison
ORIC vs HPP Comparison
Compare ORIC & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- HPP
- Stock Information
- Founded
- ORIC 2014
- HPP 1997
- Country
- ORIC United States
- HPP United States
- Employees
- ORIC N/A
- HPP N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- HPP Real Estate
- Sector
- ORIC Health Care
- HPP Finance
- Exchange
- ORIC Nasdaq
- HPP Nasdaq
- Market Cap
- ORIC 362.9M
- HPP 319.5M
- IPO Year
- ORIC 2020
- HPP 2010
- Fundamental
- Price
- ORIC $8.17
- HPP $1.86
- Analyst Decision
- ORIC Strong Buy
- HPP Hold
- Analyst Count
- ORIC 8
- HPP 10
- Target Price
- ORIC $18.83
- HPP $3.07
- AVG Volume (30 Days)
- ORIC 1.6M
- HPP 2.6M
- Earning Date
- ORIC 05-05-2025
- HPP 05-07-2025
- Dividend Yield
- ORIC N/A
- HPP 2.69%
- EPS Growth
- ORIC N/A
- HPP N/A
- EPS
- ORIC N/A
- HPP N/A
- Revenue
- ORIC N/A
- HPP $818,699,000.00
- Revenue This Year
- ORIC N/A
- HPP N/A
- Revenue Next Year
- ORIC N/A
- HPP $4.71
- P/E Ratio
- ORIC N/A
- HPP N/A
- Revenue Growth
- ORIC N/A
- HPP N/A
- 52 Week Low
- ORIC $3.90
- HPP $1.81
- 52 Week High
- ORIC $14.67
- HPP $6.29
- Technical
- Relative Strength Index (RSI)
- ORIC 72.38
- HPP 35.34
- Support Level
- ORIC $5.52
- HPP $1.87
- Resistance Level
- ORIC $8.44
- HPP $2.01
- Average True Range (ATR)
- ORIC 0.63
- HPP 0.12
- MACD
- ORIC 0.32
- HPP -0.01
- Stochastic Oscillator
- ORIC 93.11
- HPP 7.81
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About HPP Hudson Pacific Properties Inc.
Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.